1. Home
  2. INSM vs NRG Comparison

INSM vs NRG Comparison

Compare INSM & NRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • NRG
  • Stock Information
  • Founded
  • INSM 1988
  • NRG 1989
  • Country
  • INSM United States
  • NRG United States
  • Employees
  • INSM N/A
  • NRG N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • NRG Electric Utilities: Central
  • Sector
  • INSM Health Care
  • NRG Utilities
  • Exchange
  • INSM Nasdaq
  • NRG Nasdaq
  • Market Cap
  • INSM 26.0B
  • NRG 29.4B
  • IPO Year
  • INSM 2000
  • NRG 2000
  • Fundamental
  • Price
  • INSM $127.80
  • NRG $148.54
  • Analyst Decision
  • INSM Strong Buy
  • NRG Strong Buy
  • Analyst Count
  • INSM 17
  • NRG 10
  • Target Price
  • INSM $137.40
  • NRG $162.70
  • AVG Volume (30 Days)
  • INSM 3.0M
  • NRG 3.3M
  • Earning Date
  • INSM 08-07-2025
  • NRG 08-06-2025
  • Dividend Yield
  • INSM N/A
  • NRG 1.18%
  • EPS Growth
  • INSM N/A
  • NRG N/A
  • EPS
  • INSM N/A
  • NRG 2.20
  • Revenue
  • INSM $398,105,000.00
  • NRG $29,367,000,000.00
  • Revenue This Year
  • INSM $28.23
  • NRG $6.84
  • Revenue Next Year
  • INSM $119.99
  • NRG $6.43
  • P/E Ratio
  • INSM N/A
  • NRG $67.69
  • Revenue Growth
  • INSM 21.15
  • NRG 1.82
  • 52 Week Low
  • INSM $60.40
  • NRG $76.13
  • 52 Week High
  • INSM $128.48
  • NRG $175.96
  • Technical
  • Relative Strength Index (RSI)
  • INSM 85.01
  • NRG 41.89
  • Support Level
  • INSM $106.54
  • NRG $151.37
  • Resistance Level
  • INSM $128.48
  • NRG $158.98
  • Average True Range (ATR)
  • INSM 4.11
  • NRG 6.61
  • MACD
  • INSM 1.68
  • NRG -1.51
  • Stochastic Oscillator
  • INSM 97.41
  • NRG 11.43

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About NRG NRG Energy Inc.

NRG Energy is one of the largest retail energy providers in the US, with 6 million customers. Vivint Smart Home, which NRG acquired in 2023, has 2 million home services customers. NRG also is one of the largest US independent power producers, with 13 gigawatts of coal, gas, and oil power generation capacity primarily in Texas. The LS Power asset acquisition will add 13 GW of gas-fired power plants mostly in the eastern US. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.

Share on Social Networks: